Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis

Short telomeres are one of the main genetic manifestations in human cancer, as they have been shown to play an important role in inducing chromosomal instability and in contributing to tumor progression. The purpose of this study was to determine if changes in telomere length occur in serous tubal intraepithelial carcinoma (STIC), the putative precursor of “ovarian” high-grade serous carcinoma (HGSC). Twenty-two STICs from 15 patients with concurrent but discrete HGSCs were analyzed for telomere length on formalin-fixed, paraffin-embedded sections by conducting p53 immunofluorescence to assist in identifying STICs and telomere-specific FISH. Telomere length (short, long, or no change) in STICs was compared with HGSCs using normal fallopian tube epithelium and stromal cells as controls. We found that STICs had the shortest telomeres, as 18 (82%) of 22 STICs had short telomeres, whereas only 2 (9%) showed no change and 2 (9%) had long telomeres compared with the normal-looking tubal epithelium. In contrast, among 12 paired HGSCs and STICs, 6 HGSCs showed an increase in telomere length, one showed a decrease in length and 5 did not show any change when compared with their matched STICs, although, such as STICs, the majority of HGSCs had shorter telomeres than the associated normal tubal epithelial cells. These differences in telomere length between normal tubal epithelial cells and STICs, and between STICs and HGSCs were statisticaly significant (P<0.05). In conclusion, the finding of short telomeres, which have been shown to be one of the earliest molecular changes in carcinogenesis, in a vast majority of STICs provides further support to the proposal that STICs are precursors of HGSC and opens new areas of research in elucidating the early events of ovarian high-grade serous carcinogenesis.

[1]  Ie-Ming Shih,et al.  The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.

[2]  I. Shih,et al.  Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase , 2010, Modern Pathology.

[3]  J. Lubiński,et al.  Elevated level of 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls , 2009, International journal of cancer.

[4]  P. Lansdorp Telomeres and disease , 2009, The EMBO journal.

[5]  P. Shaw,et al.  Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers , 2009, Modern Pathology.

[6]  I. Shih,et al.  Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. , 2009, Cancer research.

[7]  G. Roos,et al.  Telomere length as a biological marker in malignancy. , 2009, Biochimica et biophysica acta.

[8]  N. Zaffaroni,et al.  Targeting the telosome: therapeutic implications. , 2009, Biochimica et biophysica acta.

[9]  Allan G. Rempel,et al.  Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. , 2008, Gynecologic oncology.

[10]  Kwok-Kin Wong,et al.  Differential roles of telomere attrition in type I and II endometrial carcinogenesis. , 2008, The American journal of pathology.

[11]  B. Rosen,et al.  Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from BRCA Mutation Carriers Resemble High-Grade Serous Carcinoma , 2008, Clinical Cancer Research.

[12]  J. Garber,et al.  A candidate precursor to serous carcinoma that originates in the distal fallopian tube (J Pathol 2007; 211: 26–35) , 2007, The Journal of pathology.

[13]  I. Shih,et al.  Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance , 2007, International Journal of Gynecologic Cancer.

[14]  D. Feldser,et al.  Short telomeres limit tumor progression in vivo by inducing senescence. , 2007, Cancer cell.

[15]  A. Multani,et al.  Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53‐dependent cellular senescence , 2007, EMBO reports.

[16]  R. Berkowitz,et al.  Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.

[17]  A. Meeker,et al.  Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung. , 2007, American journal of clinical pathology.

[18]  R. Drapkin,et al.  The distal fallopian tube: a new model for pelvic serous carcinogenesis , 2007, Current opinion in obstetrics & gynecology.

[19]  K. Lillemoe,et al.  Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma , 2006, Modern Pathology.

[20]  M. Muto,et al.  Advances in the Recognition of Tubal Intraepithelial Carcinoma: Applications to Cancer Screening and the Pathogenesis of Ovarian Cancer , 2006, Advances in anatomic pathology.

[21]  R. DePinho,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[22]  R. Reddel,et al.  The first molecular details of ALT in human tumor cells. , 2005, Human molecular genetics.

[23]  Gordon B Mills,et al.  Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon , 2005, Clinical Cancer Research.

[24]  J. Shay,et al.  Senescence and immortalization: role of telomeres and telomerase. , 2005, Carcinogenesis.

[25]  S. Jackson,et al.  Human cell senescence as a DNA damage response , 2005, Mechanisms of Ageing and Development.

[26]  P. Argani,et al.  Telomere Shortening Occurs Early During Breast Tumorigenesis: A Cause of Chromosome Destabilization Underlying Malignant Transformation? , 2004, Journal of Mammary Gland Biology and Neoplasia.

[27]  W. Murdoch,et al.  Oxidative Damage to DNA of Ovarian Surface Epithelial Cells Affected by Ovulation: Carcinogenic Implication and Chemoprevention , 2004, Experimental biology and medicine.

[28]  E. Montgomery,et al.  Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis , 2004, Clinical Cancer Research.

[29]  T. Cech Beginning to Understand the End of the Chromosome , 2004, Cell.

[30]  W. Gage,et al.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. , 2002, The American journal of pathology.

[31]  N. Inaba,et al.  The relationship between telomere length and telomerase activity in gynecologic cancers. , 2002, Gynecologic oncology.

[32]  T. von Zglinicki Oxidative stress shortens telomeres. , 2002, Trends in biochemical sciences.

[33]  P. V. van Diest,et al.  Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.

[34]  Rochelle L. Garcia,et al.  Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. , 2001, Gynecologic oncology.

[35]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[36]  R. Datar,et al.  Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas. , 1999, Gynecologic oncology.

[37]  F. Jänicke,et al.  Differential telomerase activity, expression of the telomerase catalytic sub‐unit and telomerase‐RNA in ovarian tumors , 1999, International journal of cancer.

[38]  R. Jensen,et al.  BRCA1 Expression Restores Radiation Resistance in BRCA1-defective Cancer Cells through Enhancement of Transcription-coupled DNA Repair* , 1999, The Journal of Biological Chemistry.

[39]  M. Egholm,et al.  Single base discrimination of CENP-B repeats on mouse and human Chromosomes with PNA-FISH , 1999, Mammalian Genome.

[40]  T. Ide,et al.  Telomerase activity in ovarian tumors , 1997, Cancer.

[41]  C. Harley,et al.  Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[43]  S. D. Mearses ENDOMETRIAL CARCINOMA. , 1963, The Medical journal of Malaya.